Table 3. OR for New-Onset Hypertension According to Baseline UACR Tertile.

	UACR at baseline
	Tertile 1	Tertile 2	Tertile 3	P for trend
Men
UACR, mg/g	<5.38	5.38–9.36	≥9.37
No. of subjects	147	147	148
No. of new-onset hypertension	14 (9.5%)	20 (13.6%)	23 (15.5%)
OR (95% CI) for new-onset hypertension
Model 1	1.00	1.47 (0.71–3.04)	1.71 (0.84–3.48)	0.146
Model 2	1.00	1.58 (0.75–3.33)	1.66 (0.79–3.48)	0.187
Model 3	1.00	1.65 (0.78–3.50)	1.83 (0.85–3.94)	0.124
Women
UACR, mg/g	<6.17	6.17–11.63	≥11.64
No. of subjects	243	244	244
No. of new-onset hypertension	11 (4.5%)	24 (9.8%)	31 (12.7%)
OR (95% CI) for new-onset hypertension
Model 1	1.00	2.20 (1.05–4.64)	2.62 (1.27–5.40)	0.008
Model 2	1.00	2.59 (1.20–5.57)	2.73 (1.29–5.78)	0.012
Model 3	1.00	2.57 (1.19–5.56)	2.69 (1.27–5.73)	0.014

UACR, urine albumin-to-creatinine ratio; OR, odds ratio; CI, confidence interval; BMI, body mass index; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; GFR, glomerular filtration rate.

Model 1: adjusted for age, Model 2: Model 1+additionally adjusted for baseline BMI, muscle mass, systolic blood pressure, diabetes mellitus, smoking, alcohol consumption, regular exercise, Model 3: Model 2+additionally adjusted for baseline fasting serum glucose, triglyceride, HDL cholesterol, hs-CRP, estimated GFR.